⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13282236 | 0.84 | — | — | |
| SCHEMBL4148264 | 0.84 | — | — | |
| SCHEMBL14525102 | 0.82 | GSR (0.46) | — | |
| SCHEMBL12037633 | 0.82 | GSR (0.46) | — | |
| SCHEMBL13282367 | 0.82 | GSR (0.46) | — | |
| SCHEMBL13410354 | 0.82 | GABRR1 (0.46) | — | |
| SCHEMBL8252368 | 0.79 | GABRR1 (0.58) | — | |
| SCHEMBL22044214 | 0.78 | — | — | |
| SCHEMBL14518787 | 0.78 | — | — | |
| SCHEMBL19689363 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230190950-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS | CIDARA THERAPEUTICS, INC. | 2023-06-22 | — | — | US | disclosed |
| US-20230165970-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS | CIDARA THERAPEUTICS, INC. | 2023-06-01 | — | — | US | disclosed |
| WO-2023004240-A1 | MACROCYLIC IMMUNOMODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-01-26 | — | — | WO | disclosed |